These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37679643)

  • 21. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.
    Dieterle MG; Putler R; Perry DA; Menon A; Abernathy-Close L; Perlman NS; Penkevich A; Standke A; Keidan M; Vendrov KC; Bergin IL; Young VB; Rao K
    mBio; 2020 May; 11(3):. PubMed ID: 32371595
    [No Abstract]   [Full Text] [Related]  

  • 22. Frontiers in antibiotic alternatives for
    Phanchana M; Harnvoravongchai P; Wongkuna S; Phetruen T; Phothichaisri W; Panturat S; Pipatthana M; Charoensutthivarakul S; Chankhamhaengdecha S; Janvilisri T
    World J Gastroenterol; 2021 Nov; 27(42):7210-7232. PubMed ID: 34876784
    [No Abstract]   [Full Text] [Related]  

  • 23. The role of toxins in Clostridium difficile infection.
    Chandrasekaran R; Lacy DB
    FEMS Microbiol Rev; 2017 Nov; 41(6):723-750. PubMed ID: 29048477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral Omilancor Treatment Ameliorates Clostridioides difficile Infection During IBD Through Novel Immunoregulatory Mechanisms Mediated by LANCL2 Activation.
    Tubau-Juni N; Bassaganya-Riera J; Leber AJ; Alva SS; Hontecillas R
    Inflamm Bowel Dis; 2024 Jan; 30(1):103-113. PubMed ID: 37436905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity.
    Lesniak NA; Schubert AM; Flynn KJ; Leslie JL; Sinani H; Bergin IL; Young VB; Schloss PD
    mBio; 2022 Aug; 13(4):e0118322. PubMed ID: 35856563
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel, non-colonizing, single-strain live biotherapeutic product ADS024 protects against
    Murphy CK; O'Donnell MM; Hegarty JW; Schulz S; Hill C; Ross RP; Rea MC; Farquhar R; Chesnel L
    World J Gastrointest Pathophysiol; 2023 Aug; 14(4):71-85. PubMed ID: 37727283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vancomycin Treatment Alters Humoral Immunity and Intestinal Microbiota in an Aged Mouse Model of Clostridium difficile Infection.
    van Opstal E; Kolling GL; Moore JH; Coquery CM; Wade NS; Loo WM; Bolick DT; Shin JH; Erickson LD; Warren CA
    J Infect Dis; 2016 Jul; 214(1):130-9. PubMed ID: 26917573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Review of Clostridioides difficile Infection and Antibiotic-Associated Diarrhea.
    Abad CLR; Safdar N
    Gastroenterol Clin North Am; 2021 Jun; 50(2):323-340. PubMed ID: 34024444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ridinilazole: a novel, narrow-spectrum antimicrobial agent targeting Clostridium (Clostridioides) difficile.
    Collins DA; Riley TV
    Lett Appl Microbiol; 2022 Sep; 75(3):526-536. PubMed ID: 35119124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clostridium difficile-induced colitis in mice is independent of leukotrienes.
    Trindade BC; Theriot CM; Leslie JL; Carlson PE; Bergin IL; Peters-Golden M; Young VB; Aronoff DM
    Anaerobe; 2014 Dec; 30():90-8. PubMed ID: 25230329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outbreak of Murine Infection with
    Mau T; Eckley SS; Bergin IL; Saund K; Villano JS; Vendrov KC; Snitkin ES; Young VB; Yung R
    mSphere; 2019 Mar; 4(2):. PubMed ID: 30894434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Case of Pseudomembranous Colitis Caused by a
    Kim HS; Kim HM; Gweon TG
    Korean J Gastroenterol; 2023 Mar; 81(3):133-136. PubMed ID: 36960697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Look What the Cat Dragged in! Recurrent Clostridioides difficile from a Household Cat.
    Garza MA; Thomas B; Saleh A; Nabbout L; Quigley EMM; Mathur N
    Am J Case Rep; 2023 Oct; 24():e940923. PubMed ID: 37885171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucosyltransferase-dependent and independent effects of Clostridioides difficile toxins during infection.
    Peritore-Galve FC; Shupe JA; Cave RJ; Childress KO; Washington MK; Kuehne SA; Lacy DB
    PLoS Pathog; 2022 Feb; 18(2):e1010323. PubMed ID: 35176123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clostridium butyricum enhances colonization resistance against Clostridioides difficile by metabolic and immune modulation.
    Hagihara M; Ariyoshi T; Kuroki Y; Eguchi S; Higashi S; Mori T; Nonogaki T; Iwasaki K; Yamashita M; Asai N; Koizumi Y; Oka K; Takahashi M; Yamagishi Y; Mikamo H
    Sci Rep; 2021 Jul; 11(1):15007. PubMed ID: 34294848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Therapeutic Mechanism of Macrophage Inflammatory Protein 1 α Neutralizing Antibody (CCL3) in Clostridium difficile Infection in Mice.
    Wang J; Ortiz C; Fontenot L; Mukhopadhyay R; Xie Y; Chen X; Feng H; Pothoulakis C; Koon HW
    J Infect Dis; 2020 Apr; 221(10):1623-1635. PubMed ID: 31793629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients.
    Fishbein SRS; Hink T; Reske KA; Cass C; Struttmann E; Iqbal ZH; Seiler S; Kwon JH; Burnham CA; Dantas G; Dubberke ER
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33441409
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
    Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
    Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CDBN-YGXZ, a Novel Small-Molecule Drug, Shows Efficacy against Clostridioides difficile Infection and Recurrence in Mouse and Hamster Infection Models.
    Hu X; Dong R; Huang S; Zeng Y; Zhan W; Gao X; Tian D; Peng J; Xu J; Wang T; Zhang Y; Wang X; Zhang X; Liu J; Guang B; Yang T
    Antimicrob Agents Chemother; 2023 May; 67(5):e0170422. PubMed ID: 37052498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites.
    Wang J; Ghali S; Xu C; Mussatto CC; Ortiz C; Lee EC; Tran DH; Jacobs JP; Lagishetty V; Faull KF; Moller T; Rossetti M; Chen X; Koon HW
    Gastroenterology; 2018 May; 154(6):1737-1750. PubMed ID: 29360463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.